Your browser doesn't support javascript.
loading
3D tumor explant as a novel platform to investigate therapeutic pathways and predictive biomarkers in cancer patients.
Rodolfo, Monica; Huber, Veronica; Cossa, Mara; Gallino, Gianfrancesco; Leone, Biagio E; Vallacchi, Viviana; Rivoltini, Licia; Vergani, Elisabetta.
Affiliation
  • Rodolfo M; Department of Experimental Oncology, Translational Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Huber V; Department of Experimental Oncology, Translational Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cossa M; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gallino G; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Leone BE; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Vallacchi V; Department of Experimental Oncology, Translational Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rivoltini L; Department of Experimental Oncology, Translational Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Vergani E; Department of Experimental Oncology, Translational Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Front Immunol ; 13: 1068091, 2022.
Article in En | MEDLINE | ID: mdl-36591316
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Italy Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Italy Country of publication: Switzerland